Edition:
United States

Atara Biotherapeutics Inc (ATRA.OQ)

ATRA.OQ on NASDAQ Stock Exchange Global Select Market

51.05USD
4:00pm EDT
Change (% chg)

$1.35 (+2.72%)
Prev Close
$49.70
Open
$49.60
Day's High
$51.25
Day's Low
$49.60
Volume
95,037
Avg. Vol
250,206
52-wk High
$54.45
52-wk Low
$11.80

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Isaac Ciechanover

46 2016 Chairman of the Board, President, Chief Executive Officer

Joseph Newell

47 2017 Executive Vice President, Chief Technical Operations Officer

Christopher Haqq

50 2012 Executive Vice President - Research and Development, Chief Scientific Officer

Heather Turner

43 2015 Executive Vice President, General Counsel, Secretary and Head of Portfolio Strategy

Mitchall Clark

55 2014 Executive Vice President and Chief Regulatory and Quality Assurance Officer